Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-06-07
2000-05-30
Celsa, Bennett
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530331, A61K 3700, C07K 500
Patent
active
060691301
ABSTRACT:
Novel compounds, their salts and compositions related thereto having activity against mammalian factor Xa are disclosed. The compounds are useful in vitro or in vivo for preventing or treating coagulation disorders.
REFERENCES:
patent: 3867364 (1975-02-01), Umezawa
patent: 4316889 (1982-02-01), Bajusz
patent: 4399065 (1983-08-01), Bajusz
patent: 4478745 (1984-10-01), Bajusz
patent: 4588587 (1986-05-01), Gasic
patent: 4593018 (1986-06-01), Austen
patent: 5153176 (1992-10-01), Abe
patent: 5371072 (1994-12-01), Webb
patent: 5380713 (1995-01-01), Balasubramanian
patent: 5523308 (1996-06-01), Costanzo
Ohta et al., "Interaction of Antistasin-related Peptides with Factor Xa: Identification of a Core Inhibitory Sequence", Thrombosis and Haemostasis 72(6) 825-830 (1994).
Almquist, R.G., et al., J Med Chem (1980) 23:1392-1398 (--COCH.sub.2 --).
Blankenship, D.T. et al., "Amino Acid Sequence of Ghilanten: Anti-coagulant-antimetastatic Principle of the South American Leech, Haementeria ghilianii," Biochem. Biophys. Res. Commun. 166, 1384-1389 (1990).
Brankamp, R.G. et al., "Ghilantens: Anticoagulants, Antimetastatic Proteins from the South American Leech Haementeria ghilianii," J. Lab. Clin. Med., 115, 89-97 (1990).
Bundgard, H., Design of Prodrugs, pp. 7-9, 21-24, Elsevier, Amsterdam 1985.
CA:97:39405 (1982) (--CH(OH)CH.sub.2 --).
Cappello, M. et al., "Ancylostoma Factor Xa Inhibitor: Partial Purification and its Identification as a Major Hookworm-derived Anticoagulant In Vitro," J. Infect. Dis., 167, 1474-1477 (1993).
Claeson, G., "Synthetic Peptides and Peptidomimetics as Substrates and Inhibitors of Thrombin and Other Protease in the Blood Coagulation System," Blood Coag. Fibrinol. 5, 411-436 (1994).
Condra, C. et al., "Isolation and Structural Characterization of a Potent Inhibitor of Coagulation Factor Xa from the Leech Haementeria ghilianii," Thromb. Haemost., 61, 437-441 (1989).
Cox, A.C., "Coagulation Factor X Inhibitor From the Hundred-pace Snake Deinagkistrodon acutus, venom," Toxicon, 31, 1445-1457 (1993).
Davie, E.J., et al., "The Coagulation Cascade: Initiation, Maintenance and Regulation," Biochemistry 30, 10363-10370 (1991).
Dondoni, A. et al., Synthesis, 1162-1176 (1993).
Edwards, P.D., et al., J. Amer. Chem. Soc., 114, 1854-1863 (1992).
Edwards, P.D., et al., J. Med. Chem. 38, 76-85 (1995).
Etingin, O.R., et al., Cell, 61, 657 (1990).
Furie, B., et al., Cell 53, 505 (1988).
Girard, T.J. et al., "Functional Significance of the Kunitz-type Inhibitory Domains of Lipoprotein-associated Coagulation Inhibitor," Nature 338, 518-520 (1989).
Hann, M.M., J Chem Soc Perkin Trans I (1982) 307-314 (--CH=CH--, cis and trans).
Hauptmann, J. et al., "Comparison of the Anticoagulant and Antithrombotic Effects of Synthetic Thrombin and Factor Xa Inhibitors," Thromb. Haemost, 63, 220-223 (1990).
Hitomi, Y. et al., "Inhibitory Effect of New Synthetic Protease Inhibitor (FUT-175) on the Coagulation System," Haemostasis, 15, 164-168 (1985).
Holladay, M.W., et al., Tetrahedron Lett (1983) 24:4401-4404 (--C(OH)CH.sub.2 --).
Hollenbach, S. et al., Thromb. Haemost. 71, 357-362 (1994).
Hoover, R.J., et al., Cell, 14, 423 (1978).
Hruby, V.J., Life Sci (1982) 31:189-199 (--CH.sub.2 --S--).
Hudson, D., et al., Int J Pept Prot Res (1979) 14:177-185 (--CH.sub.2 NH--, --CH.sub.2 CH.sub.2 --).
Jacobs, J.W. et al., "Isolation and Characterization of a Coagulation Factor Xa Inhibitor from Black Fly Salivary Glands," Thromb. Haemost., 64, 235-238 (1990).
Jennings-White, C., et al., Tetrahedron Lett (1982) 23:2533 (--COCH.sub.2 --).
Kam, C.M. et al., "Mechanism Based Isocoumarin Inhibitors for Trypsin and Blood Coagulation Serine Proteases: New Anticoagulants," Biochemistry, 27, 2547-2557 (1988).
Morley, J.S., Trends Pharm Sci (1980) pp. 463-468 (general review).
Nagahara, T. et al., "Dibasic (Amidinoaryl)propanoic Acid Derivatives as Novel Blood Coagulation Factor Xa Inhibitors," J. Med. Chem., 37, 1200-1207 (1994).
Nutt, E. et al., "The Amino Acid Sequence of Antistasin, a Potent Inhibitor of Factor Xa Reveals a Repeated Internal Structure," J. Biol. Chem., 263, 10162-10167 (1988).
Seymour, J.L. et al., "Ecotin is a Potent Anticoagulant and Reversible Tight-binding Inhibitor of Factor Xa," Biochemistry 33, 3949-3958 (1994).
Silverman, R.B., The Organic Chemistry of Drug Design and Drug Action, pp. 352-401, Academic Press, San Diego, CA 1992.
Sinha, U. et al., Thromb. Res., 75, 427-436 (1994).
Spatola, A.F., in "Chemistry and Biochemistry of Amino Acids, Peptides and Proteins," B. Weinstein, eds., Marcel Dekker, New York, p. 267-355 (1983) (general review).
Spatola, A.F., et al., Life Sci (1986) 38:1243-1249 (--CH.sub.2 --S).
Sturzebecher, J. et al., "Synthetic Inhibitors of Bovine Factor Xa and Thrombin. Comparison of Their Anticoagulant Efficiency," Thromb. Res., 54, 245-252 (1989).
Tapparelli et al., J. Biol. Chem. 268, 4734-4741 (1993).
Tidwell, R.R. et al., "Strategies for Anticoagulation With Synthetic Protease Inhibitors. Xa Inhibitors Versus Thrombin Inhibitors," Thromb Res. 19, 339-349 (1980).
Tsutsumi, S., et al., J. Med. Chem. 37, 3492-3502 (1994).
Turner, A.D. et al., "p-Amidino Esters as Irreversible Inhibitors of Factor IXa and Xa and Thrombin," Biochemistry, 25, 4929-4935 (1986).
Waxman, L. et al., "Tick Anticoagulant Peptide (TAP) is a Novel Inhibitor of Blood Coagulation Factor Xa" Science, 248, 593-596 (1990).
Marlowe Charles K.
Scarborough Robert M.
Zhu Bing-Yan
Celsa Bennett
COR Therapeutics Inc.
LandOfFree
Ketoheterocyclic inhibitors of factor Xa does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ketoheterocyclic inhibitors of factor Xa, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ketoheterocyclic inhibitors of factor Xa will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1910480